Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
Quick Stats
Jan 30, 202652.7
AI Score
HOLD0.77
Volume Ratio
Mar 16, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
LXEO Stock Summary
Last updated Jan 30, 2026
LXEO is currently trading at $7.41, positioned above its 200-day moving average of $6.19, indicating a long-term uptrend. The stock has a 52-week range of $1.45 to $10.99.
Technical Analysis: The 50-day moving average stands at $9.05, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 38.491, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.104, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates LXEO at 52.7/100 with a HOLD recommendation.
LXEO (Lexeo Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 38.491 |
| CMF (20) | 0.104 |
| ROC (10) | -1.2 |
| ADX (14) | 22.079 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.554 |
| AROONOSC (14) | -7.143 |
| WILLAMS %R (14) | -81.111 |
| MFI (14) | 12.505 |
LXEO Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
LXEO Price vs Max Options Open Interest
LXEO Max Change In Options Open Interest
LXEO Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LXEO Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LXEO Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LXEO Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Lexeo Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
LXEO Moving Averages Analysis
Lexeo Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
LXEO (Lexeo Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 7.45 |
| 20 | 8.19 |
| 30 | 8.83 |
| 50 | 9.05 |
| 100 | 8.39 |
| 200 | 6.19 |
LXEO Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 543.0 million |
| Earnings/Share ($) | -2.5 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.9225 |
| EPS Estimate Next Year ($) | -1.4716 |
| WallStreet Target Price ($) | 19.6364 |
| Most Recent Quarter |